Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000359885

Medchemexpress LLC XP-524 | 2344825-52-9 | 98.0% | 552.65 | 100 MG
SDP

Catalog No. 5000359885
Encompass_Preferred

XP-524 is a potent BET and EP300 inhibitor that demonstrates significant tumoricidal activity in vivo. It prevents KRAS-induced neoplastic transformation and extends survival in aggressive pancreatic ductal adenocarcinoma (PDAC) mouse models. This compound also enhances self-peptide presentation and tumor recruitment of cytotoxic T lymphocytes, highlighting its potential for PDAC research.

  • Potent BET and EP300 inhibitor
  • Exhibits significant tumoricidal activity in vivo
  • Prevents KRAS-induced neoplastic transformation
  • Extends survival in aggressive pancreatic ductal adenocarcinoma (PDAC) mouse models
  • Enhances self-peptide presentation and tumor recruitment of cytotoxic T lymphocytes
  • Effective against fulvestrant-resistant and tamoxifen-resistant/sensitive MCF7/T47D cells
  • Stable as powder for 3 years at -20°C
  • Stable in solvent for 6 months at -80°C or 1 month at -20°C

Catalog No. 50-003-59885 Supplier Medchemexpress LLC Supplier No. HY147008100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

XP-524 is a potent BET and EP300 inhibitor that demonstrates significant tumoricidal activity in vivo. It prevents KRAS-induced neoplastic transformation and extends survival in aggressive pancreatic ductal adenocarcinoma (PDAC) mouse models. This compound also enhances self-peptide presentation and tumor recruitment of cytotoxic T lymphocytes, highlighting its potential for PDAC research.

  • Potent BET and EP300 inhibitor
  • Exhibits significant tumoricidal activity in vivo
  • Prevents KRAS-induced neoplastic transformation
  • Extends survival in aggressive pancreatic ductal adenocarcinoma (PDAC) mouse models
  • Enhances self-peptide presentation and tumor recruitment of cytotoxic T lymphocytes
  • Effective against fulvestrant-resistant and tamoxifen-resistant/sensitive MCF7/T47D cells
  • Stable as powder for 3 years at -20°C
  • Stable in solvent for 6 months at -80°C or 1 month at -20°C

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.